Bioaffinity Technologies Warrant Stock Analysis
| BIAFW Stock | USD 0.24 0.02 9.09% |
bioAffinity Technologies Warrant is fairly valued with Real Value of 0.23 and Hype Value of 0.27. The main objective of BioAffinity Technologies stock analysis is to determine its intrinsic value, which is an estimate of what bioAffinity Technologies Warrant is worth, separate from its market price. There are two main types of BioAffinity Technologies' stock analysis: fundamental analysis and technical analysis.
The BioAffinity Technologies stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. BioAffinity Technologies is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. BioAffinity Stock trading window is adjusted to America/New York timezone.
BioAffinity |
BioAffinity Stock Analysis Notes
The company had not issued any dividends in recent years. bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company was founded in 2014 and is based in San Antonio, Texas. Bioaffinity Technologies operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 14 people. For more info on bioAffinity Technologies Warrant please contact the company at 210 698 5334 or go to https://www.bioaffinitytech.com.BioAffinity Technologies Investment Alerts
| BioAffinity Technologies is way too risky over 90 days horizon | |
| BioAffinity Technologies has some characteristics of a very speculative penny stock | |
| BioAffinity Technologies appears to be risky and price may revert if volatility continues | |
| BioAffinity Technologies has a very high chance of going through financial distress in the upcoming years | |
| bioAffinity Technologies Warrant has accumulated 1.58 M in total debt. BioAffinity Technologies has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about BioAffinity Technologies' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the revenue of 2.53 M. Net Loss for the year was (7.94 M) with profit before overhead, payroll, taxes, and interest of 3.28 M. | |
| bioAffinity Technologies Warrant has accumulated about 214.4 K in cash with (6.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08. |
BioAffinity Profitablity
The company has Profit Margin (PM) of (0.9) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.84) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.84.Technical Drivers
As of the 30th of March, BioAffinity Technologies shows the Risk Adjusted Performance of 0.0512, downside deviation of 12.36, and Semi Deviation of 10.37. BioAffinity Technologies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BioAffinity Technologies coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if BioAffinity Technologies is priced correctly, providing market reflects its regular price of 0.24 per share. As BioAffinity Technologies appears to be a penny stock we also recommend to validate its total risk alpha numbers.BioAffinity Technologies Price Movement Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BioAffinity Technologies middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BioAffinity Technologies. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
BioAffinity Technologies Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BioAffinity Technologies insiders, such as employees or executives, is commonly permitted as long as it does not rely on BioAffinity Technologies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BioAffinity Technologies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
BioAffinity Technologies Predictive Daily Indicators
BioAffinity Technologies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioAffinity Technologies stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.09 | |||
| Day Median Price | 0.24 | |||
| Day Typical Price | 0.24 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | 0.02 | |||
| Relative Strength Index | 38.46 |
BioAffinity Technologies Forecast Models
BioAffinity Technologies' time-series forecasting models are one of many BioAffinity Technologies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioAffinity Technologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About BioAffinity Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how BioAffinity Technologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioAffinity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BioAffinity Technologies. By using and applying BioAffinity Stock analysis, traders can create a robust methodology for identifying BioAffinity entry and exit points for their positions.
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company was founded in 2014 and is based in San Antonio, Texas. Bioaffinity Technologies operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding BioAffinity Technologies to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
| All Next | Launch Module |
Additional Tools for BioAffinity Stock Analysis
When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.